Horizon Space Acquisition I Corp. Warrant

NASDAQ:HSPOW USA Shell Companies
Market Cap
$387.88
Market Cap Rank
#41453 Global
#13477 in USA
Share Price
$0.04
Change (1 day)
+5.26%
52-Week Range
$0.01 - $0.08
All Time High
$0.08
About

Horizon Space Acquisition I Corp., a blank check company, focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses. The company was incorporated in 2022 and is based in New York, New York.

Horizon Space Acquisition I Corp. Warrant (HSPOW) - Net Assets

Latest net assets as of September 2025: $17.23 Million USD

Based on the latest financial reports, Horizon Space Acquisition I Corp. Warrant (HSPOW) has net assets worth $17.23 Million USD as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($23.12 Million) and total liabilities ($5.89 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $17.23 Million
% of Total Assets 74.51%
Annual Growth Rate -50.25%
5-Year Change N/A
10-Year Change N/A
Growth Volatility 34.83

Horizon Space Acquisition I Corp. Warrant - Net Assets Trend (2022–2024)

This chart illustrates how Horizon Space Acquisition I Corp. Warrant's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Horizon Space Acquisition I Corp. Warrant (2022–2024)

The table below shows the annual net assets of Horizon Space Acquisition I Corp. Warrant from 2022 to 2024.

Year Net Assets Change
2024-12-31 $16.93 Million -74.12%
2023-12-31 $65.42 Million -4.47%
2022-12-31 $68.48 Million --

Equity Component Analysis

This analysis shows how different components contribute to Horizon Space Acquisition I Corp. Warrant's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 264434900.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock $21.32 Million 125.92%
Total Equity $16.93 Million 100.00%

Horizon Space Acquisition I Corp. Warrant Competitors by Market Cap

The table below lists competitors of Horizon Space Acquisition I Corp. Warrant ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Horizon Space Acquisition I Corp. Warrant's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 65,417,045 to 16,931,087, a change of -48,485,958 (-74.1%).
  • Net income of 2,653,000 contributed positively to equity growth.
  • Dividend payments of 3,171,545 reduced retained earnings.
  • Share repurchases of 50,598,309 reduced equity.
  • Other factors increased equity by 2,630,896.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income $2.65 Million +15.67%
Dividends Paid $3.17 Million -18.73%
Share Repurchases $50.60 Million -298.85%
Other Changes $2.63 Million +15.54%
Total Change $- -74.12%

Book Value vs Market Value Analysis

This analysis compares Horizon Space Acquisition I Corp. Warrant's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.02x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2022-12-31 $41.40 $0.04 x
2023-12-31 $9.67 $0.04 x
2024-12-31 $2.16 $0.04 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Horizon Space Acquisition I Corp. Warrant utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 15.67%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.00%
  • • Asset Turnover: 0.00x
  • • Equity Multiplier: 1.26x
  • Recent ROE (15.67%) is above the historical average (6.65%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2022 -0.18% 0.00% 0.00x 1.04x $-6.97 Million
2023 4.45% 0.00% 0.00x 1.04x $-3.63 Million
2024 15.67% 0.00% 0.00x 1.26x $959.89K

Industry Comparison

This section compares Horizon Space Acquisition I Corp. Warrant's net assets metrics with peer companies in the Shell Companies industry.

Industry Context

  • Industry: Shell Companies
  • Average net assets among peers: $36,677,338
  • Average return on equity (ROE) among peers: -64.57%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Horizon Space Acquisition I Corp. Warrant (HSPOW) $17.23 Million -0.18% 0.34x $82.32K
Artius II Acquisition Inc. Class A Ordinary Shares (AACB) $-60.27K 0.00% 0.00x $198.37 Million
Artius II Acquisition Inc. Units (AACBU) $-60.27K 0.00% 0.00x $205.28 Million
Ares Acquisition Corporation II (AACT-UN) $931.34 Million 0.00% 0.08x $399.77 Million
AA Mission Acquisition Corp. (AAM-UN) $-559.90 Million 0.00% 0.00x $349.76 Million
Global Acquisitions Corporation (AASP) $3.80 Million -5.26% 0.34x $15.42 Million
ABV Consulting Inc (ABVN) $8.75K -623.31% 2.50x $461.96K
Atlantic Coastal Acquisition Corp II (ACAB) $-8.52 Million 0.00% 0.00x $2.44 Million
Annabidiol Corp (ACBD) $-501.57K 0.00% 0.00x $13.62K
ACRO Biomedical Co Ltd (ACBM) $685.87K -17.12% 0.46x $30.04K
Huaizhong Health Group Inc (ADAD) $-19.47K 0.00% 0.00x $3.15K